tirzepatide class Day 3: Mounjaro (Tirzepatide β weekly injection) Class: Dual GLP-1 and GIP receptor agonist Avg Weight Loss: ~20% of baseline weight (SURMOUNT-1 trial) FDA Status: Approved for type 2 diabetes; Fast-tracked for level 3 tirzepatide π₯ Tirzepatide
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 7 - Aug 12





&srotate=0)



















